The factory located in the city of Sibiu is the largest oncologic drugs production facility in Central and Eastern Europe (CEE).
Last week, the factory exported the first lot of 229,000 units of Imatinib mesylate, an oncologic drug used for the treatment of leukaemia. The time of delivery coincided with the expiration of patent for the Imatinib molecule on Germany and Spain’s territories. The product became generic from that time.
Polisano Pharmaceuticals covers 33,000 square meters and has over 400 equipment and manufacturing lines, with a production capacity of 32 million commercial units, the equivalent of 682 million pharmaceutical units.